These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7256782)

  • 21. Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO).
    Fitzgerald DH; Tipton KF
    J Neural Transm (Vienna); 2002 Mar; 109(3):251-65. PubMed ID: 11956949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of [14C] allylamine to isolated mitochondria from rat heart and aorta.
    Hysmith RM; Boor PJ
    Toxicology; 1987 Apr; 44(1):13-29. PubMed ID: 3105119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of biotransformation on the pharmacology of the monoamineoxidase inhibitor 5-oxo-N-(d-trans-2-phenylcyclopropyl)-1-2-pyrrolidone-carboxamide (EX-4883).
    Lowe MC; Horita A
    Eur J Pharmacol; 1973 Jan; 21(1):46-52. PubMed ID: 4709204
    [No Abstract]   [Full Text] [Related]  

  • 24. Allylamine cardiovascular toxicity.
    Boor PJ; Hysmith RM
    Toxicology; 1987 May; 44(2):129-45. PubMed ID: 3551196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple forms of monoamine oxidase in developing brain: tissue and substrate specificities.
    Shih JH; Eiduson S
    J Neurochem; 1971 Jul; 18(7):1221-7. PubMed ID: 5118879
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
    Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
    Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties of monoamine oxidase in monkey heart.
    Katayama M; Kobayashi S; Oguchi K; Yasuhara H
    Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the extraneuronal nature of cardiac monoamine oxidase in the rat.
    Horita A; Lowe MC
    Adv Biochem Psychopharmacol; 1972; 5():227-42. PubMed ID: 5054204
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
    Conklin DJ; Trent MB; Boor PJ
    Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semicarbazide-sensitive amine oxidase activity in the human heart.
    Pino R; Mazzetti L; Buffoni F
    Mol Genet Metab; 1998 May; 64(1):70-5. PubMed ID: 9682221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monoamine oxidase in organ homogenates].
    Bidard JN; Cronenberger L
    Biochimie; 1972; 54(2):155-9. PubMed ID: 5086546
    [No Abstract]   [Full Text] [Related]  

  • 32. Human blood platelet monoamine oxidase.
    Collins GG; Sandler M
    Biochem Pharmacol; 1971 Feb; 20(2):289-96. PubMed ID: 5150134
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of semicarbazide-sensitive amine oxidase attenuates myocardial ischemia-reperfusion injury in an in vivo rat model.
    Yang W; Li H; Luo H; Luo W
    Life Sci; 2011 Feb; 88(7-8):302-6. PubMed ID: 21146547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (Z)-2-(2,4-Dichlorophenoxy)methyl-3-fluoroallylamine (MDL 72638): a clorgyline analogue with surprising selectivity for monoamine oxidase type B.
    McDonald IA; Palfreyman MG; Zreika M; Bey P
    Biochem Pharmacol; 1986 Jan; 35(2):349-51. PubMed ID: 3753647
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence for a clorgyline-resistant monoamine metabolizing activity in the rat heart.
    Lyles GA; Callingham BA
    J Pharm Pharmacol; 1975 Sep; 27(9):628-91. PubMed ID: 241805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on monoamine oxidase. 5. Enzymic differences in the monoamine oxidases in the brain and liver].
    Tatsuo F
    Nihon Yakurigaku Zasshi; 1968 Jul; 64(4):393-8. PubMed ID: 4387722
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased DNA synthesis in the heart during acute allylamine cardiotoxicity.
    Boor PJ; Kretschmer N
    Res Commun Chem Pathol Pharmacol; 1990 Apr; 68(1):3-11. PubMed ID: 2345804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336).
    Fowler CJ; Eriksson M; Thorell G; Magnusson O
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):279-84. PubMed ID: 6514012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An allylamine derivative (MDL 72145) with potent irreversible inhibitory actions on rat aorta semicarbazide-sensitive amine oxidase.
    Lyles GA; Fitzpatrick CM
    J Pharm Pharmacol; 1985 May; 37(5):329-35. PubMed ID: 2862241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by pargyline of cardiovascular amine oxidase activity.
    Fuentes JA; Neff NH
    Biochem Pharmacol; 1977 Nov; 26(22):2107-12. PubMed ID: 588291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.